Table 3.
Motivations for participation in an HIV vaccine trial by sex
| Categorical statements | Men n(%) | Women n(%) | Total n(%) |
|---|---|---|---|
| Volunteerism to rescue lives of others [altruism] | 64 (34.8) | 32 (55.2) | 96 (39.7)** |
| Desire to become a role model, to be among the enthusiasts | 32 (17.4) | 13 (22.4) | 45 (18.6) |
| Researchers’ explanations about HIV/AIDS vaccine studies | 36 (19.6) | 1 (1.7) | 37(15.3)*** |
| To get more knowledge about HIV prevention/vaccine | 27 (14.7) | 10 (17.2) | 37 (15.3) |
| To know my health status [know health status] | 29 (15.8) | 7 (12.1) | 36 (14.9) |
| To get knowledge for educating others about HIV or vaccine | 29 (15.8) | 5 (8.6) | 34 (14.0) |
| To cooperate with researchers in developing an HIV vaccine | 21 (11.4) | 2 (3.4) | 23 (9.5)* |
| To accomplish personal motivation | 14 (7.6) | 5 (8.6) | 19 (7.9) |
| To get protection against HIV infection | 13 (7.1) | 4 (6.9) | 17 (7.0) |
| Magnitude of the disease [AIDS] | 14 (7.6) | 3 (5.2) | 17 (7.0) |
| Severity of the disease in families – experienced death of a relative due to AIDS | 13 (7.1) | 2 (3.4) | 15 (6.2) |
| Others (free treatment/insurance, test the strength of vaccine in the body) | 6 (3.3) | 1 (1.7) | 7 (2.9) |
Significance denoted by: *** = P < 0.001; ** = P < 0.01; * = P < 0.05
NB: The columns represent multiple responses, and thus cannot add up to 100 %. The same applies to the total number of respondents in each column